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One of the central  questions  in  immunology concerns specific regulation  of 
antibody responses. Jerne (1) proposed that  interactions  between idiotype (Id) 1 
and antiidiotype (anti-Id) constitute a key element in such regulation,  leading to 
the concept of immunoregulatory  networks.  Subsequently, numerous examples 
of idiotypic regulation have been described. The production of anti-Id antibody 
has  been  demonstrated  during  normal  immune  responses  (2-4).  In  addition, 
exogenously administered anti-Id antibody has been found to regulate relevant 
Id-specific antibody  responses  (5-9)  and  to  induce  suppressor  T  lymphocytes 
(10-13).  In classical systems (15), treatment  of animals with anti-Id leads to the 
induction of antigen-nonbinding  Id-positive molecules. 
In our laboratory extensive studies of anti-major  histocompatibility complex 
(MHC) Id have been performed in recent years (16-19). Among the xenogeneic 
anti-Id reagents that have been raised are several against anti-H-2K  k monoclonal 
antibodies (8,  20). Treatment of mice in vivo with those xenogeneic anti-Id has 
been found to induce the production  of serum antibodies (Id') that  bear some 
of the idiotopes of the original  monoclonal anti-MHC antibody, but which have 
unknown binding specificity. In addition,  some mice treated with anti-Id devel- 
oped antigen-binding  activity for the original  MHC antigen,  even though  they 
had never been exposed to that antigen (20). 
In the present report we examine the Id network involved in immune responses 
to  MHC  antigens.  The  effect of subsequent  immunization  of anti-Id-primed 
mice with the original  MHC antigen was examined.  The experiments described 
here demonstrate that boosting with skin grafts bearing the original H-2 antigens 
leads to increased levels of Id'-positive, antigen-nonbinding  molecules, as well as 
antigen-binding  molecules,  in  the  serum  of the  immunized  mice.  In  contrast, 
boosting  with  other  irrelevant  antigens  had  no  effect  on  either  Id-positive 
population. These findings support strongly the existence of network interactions 
invoked after anti-Id treatment that may be involved in the control of subsequent 
responses to H-2 antigens. 
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NMS, normal mouse serum; NPIg, normal pig lg; PBS, phosphate-buffered saline. 
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Materials  and  Methods 
Animals.  BALB/cAnN mice were obtained from Charles River Breeding Laboratories, 
Inc.  (Wilmington,  MA).  BALB.K  mice  were  bred  in  our  animal  colonies.  B10.A  and 
B 10.D2 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). F-344 rats 
were purchased from the NCI-Frederick Cancer Research Facility (Frederick,  MD). 
Monoclonal Antibodies.  Clone  11-4.1  (IgG2a,K) was raised in a  BALB/c mouse immu- 
nized with  CKB spleen  cells by Oi et al.  (21) and  obtained through The Salk  Institute 
(San  Diego, CA).  The antibodies  of this  clone are  specific for the  H-2K  k antigen  with 
crossreactivities against antigens of the K q and the H-2  p'r haplotypes. The myeloma LPC- 
1 (IgG2a,x) was obtained from Dr. M. Potter. 
Preparation  ofXenogeneic  Anti4d.  Miniature swine and rabbits were immunized with 
protein A-purified 11-4.1 antibodies in complete Freund's adjuvant by several intraperi- 
toneal  injections.  Details  of the  immunization  scheme and  preparation  of anti-ld  have 
been described previously (20). Briefly, immune sera were fractionated on Sepharose 4B 
coupled with LPC-1 to remove antibodies to normal mouse Ig. This procedure has been 
shown previously to remove all anti-constant region antibodies (20). This procedure was 
repeated several times to ensure the removal of anti-constant region antibodies.  Specific 
anti-Id  antibodies  were  then  obtained  by  affinity  chromatography  on  Sepharose  4B 
coupled with  11-4.1  monoclonal antibody. 
In Vivo Treatment of Mice.  BALB/c mice were injected intraperitoneally with 20 tag of 
pig  anti-ld  in  phosphate-buffered  saline  (PBS)  on  day  0  and  3.  Control  mice  were 
immunized with 20 tag purified normal pig Ig (NPIg) on day 0 and 3. Id' levels, assessed 
by enzyme-linked inmmnosorbent assay (ELISA), were detectable within 7 d after immu- 
nization.  Skin  grafting of mice  was performed  using tail  skin  from either  BALB.K or 
B10.D2 mice or Fisher rats. Sera of skin grafted mice were usually tested 21 d after skin 
grafting. In some experiments skin-grafted mice were boosted by interperitoneal injection 
of 1 x  10 v spleen cells.  Sera were collected  1 wk after each immunization. 
ELISA Inhibition  Assay for Detection of ld.  ELISA assays were performed as described 
in  detail  previously  (9).  Briefly,  microELISA plates  (Nunc,  Roskilde,  Denmark)  were 
coated with 200 tal of protein A-purified  11-4.1 antibodies at  1 tag/ml in PBS overnight 
at 4°C. The ELISA assay was performed in 0.05%  PBS-Tween 20 (Sigma Chemical Co., 
St. Louis, MO) to reduce nonspecific binding. 
Test sera from either pig anti-Id' or NPIg-immunized mice were serially diluted in 25- 
50  ul  volumes  and  incubated  with  25  tal  of NPIg (2  tag/ml)  to  inhibit  potential  anti- 
constant region antibodies.  Simultaneously, anti-Id preparation was diluted to the appro- 
priate concentration and swamped with  10% normal mouse serum (NMS). Rabbit anti-Id 
preparation was used to avoid inhibition by anti(anti-Id) antibodies. 
After these preincubations, rabbit anti-Id was added to the test sera, and the mixtures 
were incubated for 60 min and transferred  to the  11-4.1-coated ELISA plates.  Binding 
of rabbit  anti-Id to the  11-4.1-coated plate was detected  60 rain  later  wtih  horseradish 
peroxidase-coupled  goat anti-rabbit  IgG (Cappel  Laboratories,  Cocbranville,  PA).  En- 
zyme bound  to plates  was then  exposed  to an excess of substrate,  o-phenylenediamine 
(Aldrich Chemical Co., Milwaukee, WI). The reaction was stopped by adding 8 N H2S04. 
Absorbance at 492 nm was measured by a TiterTek  Multiskan spectrophotometer (Flow 
Laboratories,  McLean, VA). Standard errors were always <10%.  Percent inhibition was 
calculated according to the formula: percent inhibition  =  [0D492  (uninhibited)  -  00492 
(test sample)/OD4.~2  (uninhibited)]  x  100. 
Complement-mediated Cytotoxicity.  Two stage microcytotoxicity assays were performed 
as described  previously (22)  using media  199  (Gibco  Laboratories,  Grand  Island,  NY) 
containing  10%  fetal  calf serum  (FCS).  5  x  104 5~Cr-labeled  target  cells  in  25  tal  were 
mixed with 25 tal of various antiserum  dilutions in microtiter wells,  incubated  15 min at 
37°C,  washed,  and  then  treated  for 30  min at  37°C with  appropriately diluted  rabbit 
complement (C'). Lysis was determined by counting 5~Cr released from the labeled target 
cells.  Percent  lysis was calculated  by the  formula: specific 5~Cr release  =  [experimental 
(cpm) -  complement alone (cpm)/maximum (cpm) -  complement alone (cpm)] x  100. 
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fluorescence-activated  cell sorter (FACS II; Becton Dickinson Immunocytometry  Systems, 
Mountain  View,  CA).  Detailed  procedures  for  the  operation  of the  sorter  and  data 
collected  have  been  reported  previously (23).  1  x  106  B10.A  lymph node cells were 
incubated for 45 rain at 4 °C with 25 #1 of a mixture of fluoresceinated goat F(ab')z anti- 
mouse lgG2 and F(ab').~ anti-mouse IgG1 at a  final dilution of 1:64 of each antibody. 
The suspension was incubated for 30 min at 4°C, washed, and resuspended in 0.4 ml for 
analysis by FMF. All staining procedures were carried out in Hanks' balanced salt solution 
containing 0.1% bovine serum albumin (BSA) and 0.1% sodium azide. Fluorescence data 
were collected using 5 x  104 viable cells as determined by forward light scatter intensity 
and the results were displayed as a  curve with cell number plotted on the ordinate and 
fluorescence intensity on the abscissa. Fluorescence units were arbitrary values selected 
on the basis of the fluorescence intensity of positively stained cells. 
Absorption Procedure.  Sera  from  anti-Id-treated  mice  were  absorbed  with  either 
BALB.K spleen cells or BALB/c spleen cells at  100 #1 of serum per  1-3  X  l0  s washed, 
packed spleen cells. The absorption mixtures were kept  1 h  at 4°C, mixed occasionally, 
centrifuged, and the supernates were collected. 
Results 
In  Vivo Treatment of Mice with Anti-ld.  We have previously reported (8,  20) 
that  BALB/c  mice  treated  with  pig anti-11.4.1  anti-ld  produced  Id'-bearing 
molecules  capable  of inhibiting  the  binding  of anti-11-4.1  anti-Id  to  11-4.1- 
coated  ELISA  plates.  A  time  course  study  (Fig.  1)  demonstrated  that,  after 
injection of 20 #g of pig anti-11-4.1  on days 0 and 3, significant serum levels of 
Id'-bearing  molecules,  which  inhibited  the  binding  of anti-Id  to  11-4.1-coated 
plates, were detected as early as day 7 and were present at the same high  level 
at  least  3  wk after  treatment.  At week 5,  in  a  high  proportion  of the  in  vivo 
immunized  mice,  the level of Id'  serum  reactivity began to decrease.  At week 
10, only a  low level of Id'  molecules could still  be detected in the immune sera 
(Fig.  1).  As  has  been  previously  reported  (25)  only  20%  of  such  anti-Id- 
immunized  mice developed detectable anti-H-2K k activity,  as assessed by cell- 
bound fluorescence quantified by FMF on the FACS (not shown). 
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F~C,  URE  1.  Induction of Id-positive molecules by in vivo treatment. Individual BALB/c mice 
were treated with either 20 #g of pig anti-ld (0) or 20 ug of NPIg (O) on day 0 and 3 and 
their sera subsequently assayed for their ability to inhibit the binding of rabbit anti-ld to Id- 
coated ELISA plates, as described in Materials and Methods. 748  REGULATORY  IDIOTYPIC  NETWORK  TO  H-2  ANTIGENS 
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FIGURE 2.  The effect of alloimmunization on the induction of Id-positive molecules and 
cytotoxic antibodies. BALB/c mice were skin grafted with BALB.K tail skin. 3 wk later sera 
from individual mice were tested for their ability to either inhibit the binding of rabbit anti- 
Id  to  Id-coated  ELISA plates (O)  or  to  lyse B10.A spleen cells (O)  in  the  presence  of 
complement. 
In  contrast  to anti-Id  immunization,  treatment  of BALB/c mice with  20  ug 
NPIg did  not  induce any significant level  of Id'  molecules  (Fig.  1)  above  the 
inhibition seen by NMS.  None of the mice so treated developed detectable anti- 
H-2K  k activity. 
Treatment  of Naive  BALB/c  Mice  with H-2K k.  It  was  of interest  to  examine 
whether  alloimmunization  with  H-2K  k antigen  would  have  any  effect on  the 
induction  of  Id'-bearing  molecules.  Alloantisera  to  H-2K  k antigen,  obtained 
from BALB/c mice that  were skin  grafted with  BALB.K tail skin,  were tested 
for their ability to inhibit  the binding of xenogeneic anti-11-4.1  anti-Id to  11- 
4.1-coated ELISA plates.  Inhibition of Id-anti-Id interaction in ELISA was not 
detectable with any of the alloantisera tested (Fig. 2).  In contrast, all of the sera 
tested showed a  significant anti-H-2K  k reactivity when assayed by microcytotox- 
icity analysis (Fig. 2) or by direct cell-bound fluorescence quantified by FMF (not 
shown).  These  results  suggested  that  the  majority  of  anti-H-2K  k  antibodies 
induced  in  BALB/c  mice  by  BALB.K  skin  grafts  do  not  express  the  11-4.1 
idiotype. 
Treatment of Anti-11-4. I Anti-Id-treated BALB/c Mice with H-2K k Antigen.  The 
effect of alloimmunization on the expression of Id-bearing molecules in anti-Id- 
treated  mice was  next examined.  Both anti-Id-primed  mice and  NPIg-treated 
mice were grafted with BALB.K skin. Skin grafting was performed 7 wk or more 
after Id' molecules decreased. Sera from anti-Id-primed BALB/c mice contained 
levels of Id' serum reactivity after skin grafting with BALB.K skin, which were 
as high as the level of Id' detected immediately after immunization with anti-Id 
(Figs.  3A  and  5).  In  contrast,  NPIg-primed  mice  that  were  skin  grafted  with 
BALB.K skin did not show any significant amount of Id' serum reactivity when 
tested by ELISA inhibition assay (Fig. 3B). 
The increased serum  levels of Id'  molecules in  sera of anti-Id-primed  mice 
was first evident after skin grafts were fully rejected, and remained at the same 
high level for at least 3 wk. The amount of Id' molecules continued to decrease RABINOWITZ,  BLUESTONE,  AND  SACHS  749 
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FIGURE  3.  The  effect  of  subsequent  anti-H-2K  k  immunization  on  Id-bearing  molecules. 
BALB/c mice were first treated with either 20 ug of pig anti-ld (A) or 20 ug NPIg (B) on day 
0  and 3. Skin grafting of the mice was performed 7  wk later using tail skin of BALB.K. The 
ability of sera from individual mice to inhibit the binding of rabbit anti-Id to Id-coated ELISA 
plates was tested at different time intervals before and after skin grafting. 
until skin  grafts were  fully rejected,  but  increased thereafter.  These  findings 
suggested that the increased level in  Id'  molecules after skin grafting was  the 
result of an antigenic stimulation. Absorption studies were performed to deter- 
mine whether the increased level of Id'-binding molecules that could now be 
detected in the sera of anti-Id-primed mice by ELISA represented an increase 
in the amount of anti-H-2K  k Id-positive antibodies or antigen-nonbinding mole- 
cules. In all sera tested, anti-H-2K  k reactivity, as detected by a microcytotoxicity 
assay, was fully removed by absorption with BALB.K spleen cells (Fig. 4, Table 
I).  In two of four individual sera, such absorption (which removes all anti-H-2  k 
activity, data not shown) did not have any effect on the capacity of the sera to 
inhibit the Id-anti-Id interaction in the ELISA (Fig. 4, Table I).  In sera from 
mice 1279 and 1284, absorption with BALB.K spleen cells partially removed the 
inhibitory capacity of the sera.  However, the level of Id' was still  greater than 
that  observed  before  skin  grafting.  These  findings suggest  that  the  level  of 
antigen-nonbinding Id' increased after exposure to the H-2K  k antigen. 
Effect  of Irrelevant Antigen Immunization  on ld'-bearing Molecules.  The above 
described experiments could be the result of either specific Id-anti-Id interac- 
tions or of a nonspecific effect of antigen immunization. To distinguish among 
these possibilities, anti-Id-primed mice were skin grafted with either  B10.D2 750  REGULATORY  1DIOTYPIC  NETWORK  TO  H-2  ANTIGENS 
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FIGURE  4.  The effect of absorption of anti-H-2K  k activity on the level of Id  + molecules and 
cytotoxic antibodies. Mouse 1276 was first immunized with pig anti-Id and then skin grafted 
with BALB.K tail  skin as described in  Fig.  3.  Three  weeks after skin grafting, serum from 
mouse  1276  was  absorbed  with  either  BALB/c  spleen cells  or  BALB.K  spleen  cells,  and 
thereafter  the  absorbed  sera  were  tested  for  their  ability  to  either  inhibit  the  Id-anti-ld 
interaction in ELISA (right) or to lyse in the presence of complement and B10.A target cells 
(/eJ2); unabsorbed serum (@), serum ~t~osorbed with BALB/c spleen cells (I),  sermn absorbed 
with BALB.K spleen cells (A). 
TABLE  I 
Effect of Absorption of Anti-H-2K k Activity on the Level of ld' 
Molecules 
Mouse 
No. 
Percent inhibition of anti-ld binding 
Before  After skin graft  skin graft 
Unab-  Absorbed  Absorbed  Unabsorbed  sorbed  with  with  serum  serum  BALB/c  BALB.K 
1284  43  65  58  50 
1276  NT  72  68  66 
1985  27  46  43  40 
1979  23  58  60  41 
BALB/c mice were first immunized on day 0  and 3  with pig anti-Id and 
then skin grafted on week 7 with BALB.K tail skin. Sera from individual 
mice were collected before and after skin grafting, absorbed with either 
BALB/c spleen cells or BALB.K spleen cells, and tested for their ability 
to inhibit the binding of rabbit anti-ld to Id-coated ELISA plates. 
(i.e.,  a  source  for a  non-H-2  antigen)  or  rat  skin  (a  source  for  a  xenogeneic 
antigen), and the sera of the skin-grafted mice were tested for their capacity to 
inhibit  Id-anti-Id  binding  in  EL1SA.  Figs.  5-7  describe  the  results  of such 
experiments.  In contrast to BALB.K skin, which induced a  high serum level of 
Id' molecules (Fig. 5), neither B10.D2 skin (Fig. 6) nor rat skin (Fig. 7) had any 
effect on  the  level  of Id'  reactivity.  When  the  various  sera  were  tested  in  a 
microcytotoxicity assay for the presence of antibody activity against the appro- 
priate  spleen  cells,  although  both  BALB.K and  rat  skin induced a  significant 
level of cytotoxic antibodies (100%  killing of the appropriate  spleen cells with RABINOW1TZ,  BLUESTONE,  AND  SACHS 
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FIGURE  5.  The  effect  of subsequent  immunization  with  BALB.K  tissues on  Id'-bearing 
molecules. BALB/c mice first immunized with pig anti-Id were skin grafted  17 wk after anti- 
Id  injection  with  BALB.K tail  skin.  Boosting with  BALB.K spleen cells were  performed  at 
weeks 23 and 25. Sera  from individual mice were assayed for their ability to inhibit ]d-anti- 
Id interaction in ELISA at different time intervals during the immunization schedule. 
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FIGURE  6.  The  effect  of  subsequent  immunization  with  B10.D2  tissues  on  Id'-bearing 
molecules. BALB/c mice first immunized with pig anti-Id were skin grafted  17 wk after anti- 
Id injection with B10.D2 tail skin. Boosting with B10.D2 spleen cells were performed at weeks 
23  and  25.  Sera  from  individual  mice  were  assayed  for  their  ability  to  inhibit  Id-anti-Id 
interaction in ELISA at different time intervals during the immunization schedule. 
titers of 1:27 to  1:81),  B10.D2  skin did not induce detectable antibody activity 
(cytotoxic titers,  <2).  Additional  boosting of the mice with B10.D2  spleen cells 
led to increased levels of cytotoxic antibodies (titers 1:16 to 1:32 after the second 
injection), but did not have any significant effect on the level of Id' reactivity in 
the immune sera (Fig. 6). Boosting of the mice with BALB.K  spleen cells led to 
increased  cytotoxic  titers  (titers  1:81  to  1:243  after  the  second  injection)  and 
persistent high levels of Id' reactivity in the immune sera tested (Fig.  5). These 
results indicated that only the original H-2K k antigen affected the production of 
Id  + antigen-nonbinding molecules. 752  REGULATORY  ]DIOTYPIC  NETWORK  TO  H-2  ANTIGENS 
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FIGURE  7.  The effect of subsequent immunization with  rat  skin on  ld-bearing molecules. 
BALB/c mice first immunized with pig anti-ld were skin grafted  14 wk after anti-Id injection 
with rat tail skin. The ability of sera from individual mice to inhibit the binding of rabbit anti- 
Id  to  Id-coated  ELISA  plates  was  tested  at  different  time  intervals  before  and  after  skin 
grafting, 
Discussion 
The experiments described in the present study demonstrate the ability of H- 
2K  k antigen  to affect specifically the product of Ig molecules bearing the same 
idiotypic  determinants  as  11-4.1,  but  without  detectable  reactivity  with  the 
immunizing  H-2K  k antigen. 
The  generation  of antigen-nonbinding  Id'-positive  molecules  after  anti-Id 
immunization  has previously been reported in several experimental systems (14, 
15,  26,  19) including  the anti-H-2K  k system studied  here  (8,  20,  24,  25,  30). 
This phenomenon suggests that anti-ld in some way triggers the expansion of B 
cell clones bearing similar idiotypic determinants to those toward which the anti- 
Id is directed. The actual mechanism involved in the regulation of such idiotype- 
positive B cell  clones is still  unknown.  Bluestone et al.  (16) found that  F(ab')2 
fragments  of rabbit  anti-11-4.1  did  not  lead  to  the  production  of Id'-positive 
molecules.  On the  basis of this  finding,  it was suggested that  the expansion  of 
those  B  cell  clones  is,  in  part,  dependent  on  T  cell  helper  factors  probably 
generated  by  recognition  of  Fc  molecules  as  carrier  determinants  (14).  Our 
present  findings,  that  only  BALB.K  skin  bearing  the  H-2K  k antigen  but  not 
B 10.D2 or rat skin boosted the serum level of antigen-nonbinding  Id' molecules, 
could be interpreted as indicating that H-2K  k antigen triggered in a specific way 
B cell clones secreting low affinity antigen-binding  antibodies that could not be 
detected by binding to test cells. Alternatively, H-2K  k antigen, like anti-Id, could 
trigger antigen-nonbinding  idiotype-positive B cell clones. If the latter explana- 
tion is correct, our findings suggest strongly the existence of Id-anti-Id regula- 
tory networks in the response to H-2K  k antigen. Thus, the administration  of H- 
2K  k antigen  may induce in mice a syngeneic anti-Id antibody or T  cell response 
which, like xenogeneic anti-Id, restimulates those B cell clones bearing the same 
idiotypic determinants.  Indeed, it has previously been reported (24) that synge- RABINOWITZ,  BLUESTONE,  AND  SACHS  753 
neic  anti-ld  antibodies  against  monoclonal  anti-H-2  antibodies  recognize  idi- 
otypes on antibodies induced by xenogeneic antMd reagents. 
To demonstrate the existence of such an Id-anti-Id  regulatory mechanism in 
the response to H-2K  k antigen, it was necessary to use anti-Id-primed mice. Skin 
grafting  of  normal  BALB/c  mice  with  BALB.K  skin  did  not  generate  any 
detectable idiotypic activity when tested in ELISA, probably because the  11-4.1 
idiotype, used to generate the anti-Id reagent,  constitutes a very minor propor- 
tion  of the  humoral  response  to  H-2K  k antigen,  and  therefore  could  not  be 
detected  in  ELISA  due  to  the  sensitivity  of the  assay.  In  manipulated  mice, 
however, Id that ordinarily constitute only a minor proportion had been induced 
by antMdiotype to represent a very large proportion of that same response. This 
provides an experimental  model for studying the concept of immunoregulatory 
network. 
Using another experimental system and the cell-bound fluorescence inhibition 
assay (20),  in some conventional  anti-H-2K  k alloantisera  that  did not show any 
idiotypic activity in  ELISA,  a  fraction  of the  antigen-binding  molecules  were 
found to possess the  11-4.1  Id (unpublished data). This finding is different from 
one previously reported (25) and may suggest that the  11-4.1  Id is more public 
than previously thought. 
The  actual  cellular  pathway  involved in  B  cell  stimulation  by anti-Id  is  still 
unknown. Experiments done in nu/nu mice both in the antinuclease system (29) 
and anti-H-2K k system (25) indicate that  B cell stimulation  by anti-Id  requires 
functional  T  cells. The  experiments  reported  here do not directly address  the 
issue of T  cell  involvement  in  the expression  of anti-H-2  B  cell  Id.  However, 
taking  into consideration  the fact that  B cell surface receptors are identical  to 
their  secreted antibodies,  it  is unlikely  that  H-2K  k antigen  which  restimulated 
the secretion of antigen-nonbinding  Id'  molecules had  bound directly to those 
B  cells that  secreted  non-H-2Kk-binding  antibodies.  Thus,  intermediate  path- 
ways, possibly involving T  cells, may operate to produce this effect. The exact 
nature  of such pathways remains  uncertain.  The  simplest  explanation  may be 
that  H-2K  k antigen  acts directly on  Id-bearing,  antigen-specific  B cells.  Subse- 
quently,  such  B  cells or their  product  might  induce  anti-Id  helper  T  cells (or 
antibodies) which, in turn, activate Id'-binding and -nonbinding B cell clones. 
Summary 
Treatment  of BALB/c mice with purified pig antiidiotype to  11-4. I  (anti-H- 
2K k) monoclonal antibody has been found previously to induce the appearance 
of idiotype-bearing molecules (Id') in the serum of these mice, in the absence of 
detectable antigen-binding activity. In the present study we examined the effect 
of subsequent immunization  of such antiidiotype-primed mice with the original 
H-2K  k antigen.  Skin grafting of virgin BALB/c mice with BALB.K skin did not 
generate any detectable Id'  antibodies when tested by enzyme-linked immuno- 
sorbent  assay (EL1SA).  In  contrast,  grafting  of antiidiotype-primed  mice  with 
BALB.K skin specifically boosted the serum level of Id' molecules. Challenge of 
antiidiotype-primed  mice  with  either  B10.D2  or rat  skin  had  no effect on  the 
production  of such  ld'  molecules.  Absorption  studies  demonstrated  that  the 
majority of ld'  molecules induced by H-2K  k antigenic stimulus and detected in 754  REGULATORY  IDIOTYPIC NETWORK  TO  H-2  ANTIGENS 
ELISA are antigen-nonbinding  molecules, thus indicating specific restimulation 
by the original H-2K  k antigen of nonbinding idiotype-positive B cell clones. The 
relevance of these findings to the existence of network interactions in the immune 
response to H-2 antigens is discussed. 
Received for publication  7 March 1985 and in revised form 24 April 1985. 
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